Crosspoint Capital Strategies, LLC Tandem Diabetes Care Inc Transaction History

Crosspoint Capital Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$101.89 - $150.09 $3.59 Million - $5.28 Million	-35,196 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$32.25 - $73.56 $1.14 Million - $2.59 Million	35,196 New	35,196 $2.24 Million
Q4 2018 Feb 13, 2019	SELL	$28.45 - $40.65 $3.59 Million - $5.13 Million	-126,282 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$21.39 - $51.17 $60,277 - $144,197	-2,818 Reduced 2.18%	126,282 $5.41 Million
Q2 2018 Aug 13, 2018	BUY	$4.9 - $23.64 $632,590 - $3.05 Million	129,100 New	129,100 $2.84 Million

360

72.2M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.31B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Crosspoint Capital Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Crosspoint Capital Strategies, LLC with notifications on news.